These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 10484981)
1. Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family. Güran S; Tunca Y; Imirzalioğlu N Cancer Genet Cytogenet; 1999 Sep; 113(2):145-51. PubMed ID: 10484981 [TBL] [Abstract][Full Text] [Related]
2. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia. Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444 [TBL] [Abstract][Full Text] [Related]
3. Cumulation of TP53 mutations and p16INK4A/p15INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer. Güran S; Pak I Cancer Genet Cytogenet; 1999 Mar; 109(2):108-13. PubMed ID: 10087941 [TBL] [Abstract][Full Text] [Related]
4. p53 and p16INK4A mutations during the progression of glomus tumor. Güran S; Tali ET Pathol Oncol Res; 1999; 5(1):41-5. PubMed ID: 10079377 [TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R; Shiohara M; Koeffler HP; Fagin JA Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724 [TBL] [Abstract][Full Text] [Related]
6. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families. Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494 [TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. Xing EP; Nie Y; Wang LD; Yang GY; Yang CS Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853 [TBL] [Abstract][Full Text] [Related]
8. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes. Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481 [TBL] [Abstract][Full Text] [Related]
9. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines. Fujishita T; Mizushima Y; Kashii T; Kobayashi M Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367 [TBL] [Abstract][Full Text] [Related]
10. Infrequent mutations of p16INK4A and p15INK4B genes in human pituitary adenomas. Yoshimoto K; Tanaka C; Yamada S; Kimura T; Iwahana H; Sano T; Itakura M Eur J Endocrinol; 1997 Jan; 136(1):74-80. PubMed ID: 9037130 [TBL] [Abstract][Full Text] [Related]
11. Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas. Zhuang SM; Schippert A; Haugen-Strano A; Wiseman RW; Söderkvist P Oncogene; 1998 Feb; 16(6):803-8. PubMed ID: 9488045 [TBL] [Abstract][Full Text] [Related]
13. Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage. De Moura J; Kavalec FL; Doghman M; Rosati R; Custodio G; Lalli E; Cavallari GM; Santa Maria J; Figueiredo BC Int J Oncol; 2010 Apr; 36(4):983-90. PubMed ID: 20198344 [TBL] [Abstract][Full Text] [Related]
14. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S; JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041 [TBL] [Abstract][Full Text] [Related]
15. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile. Franceschi S; Spugnesi L; Aretini P; Lessi F; Scarpitta R; Galli A; Congregati C; Caligo MA; Mazzanti CM Carcinogenesis; 2017 Sep; 38(9):938-943. PubMed ID: 28911001 [TBL] [Abstract][Full Text] [Related]
16. A Li-Fraumeni syndrome family with retained heterozygosity for a germline TP53 mutation in two tumors. Trkova M; Foretova L; Kodet R; Hedvicakova P; Sedlacek Z Cancer Genet Cytogenet; 2003 Aug; 145(1):60-4. PubMed ID: 12885464 [TBL] [Abstract][Full Text] [Related]
17. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689 [TBL] [Abstract][Full Text] [Related]
18. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome. Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931 [TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. Heidenreich A; Gaddipati JP; Moul JW; Srivastava S J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401 [TBL] [Abstract][Full Text] [Related]
20. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil. Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]